Literature DB >> 15322106

Differential sensitivity of phosphatidylinositol 3-kinase p110gamma to isoforms of G protein betagamma dimers.

Kristi R Kerchner1, Robert L Clay, Gavin McCleery, Nikki Watson, William E McIntire, Chang-Seon Myung, James C Garrison.   

Abstract

The ability of G protein alpha and betagamma subunits to activate the p110gamma isoform of phosphatidylinositol 3-kinase (PtdIns 3-kinase) was examined using pure, recombinant G proteins and the p101/p110gamma form of PtdIns 3-kinase reconstituted into synthetic lipid vesicles. GTP-activated Gs, Gi, Gq, or Go alpha subunits were unable to activate PtdIns 3-kinase. Dimers containing Gbeta(1-4) complexed with gamma2-stimulated PtdIns 3-kinase activity about 26-fold with EC50 values ranging from 4 to 7 nm. Gbeta5gamma2 was not able to stimulate PtdIns 3-kinase despite producing a 10-fold activation of avian phospholipase Cbeta. A series of dimers with beta subunits containing point mutations in the amino acids that undergo a conformational change upon interaction of betagamma with phosducin (beta1H311Agamma2, beta1R314Agamma2, and beta1W332Agamma2) was tested, and only beta1W332Agamma2 inhibited the ability of the dimer to stimulate PtdIns 3-kinase. Dimers containing the beta1 subunit complexed with a panel of different Ggamma subunits displayed variation in their ability to stimulate PtdIns 3-kinase. The beta1gamma2, beta1gamma10, beta1gamma12, and beta1gamma13 dimers all activated PtdIns 3-kinase about 26-fold with 4-25 nm EC50 values. The beta1gamma11 dimer, which contains the farnesyl isoprenoid group and is highly expressed in tissues containing the p101/p110gamma form of PtdIns 3-kinase, was ineffective. The role of the prenyl group on the gamma subunit in determining the activation of PtdIns 3-kinase was examined using gamma subunits with altered CAAX boxes directing the addition of farnesyl to the gamma2 subunit and geranylgeranyl to the gamma1 and gamma11 subunits. Replacement of the geranylgeranyl group of the gamma2 subunit with farnesyl inhibited the activity of beta1gamma2 on PtdIns 3-kinase. Conversely, replacement of the farnesyl group on the gamma1 and gamma11 subunit with geranylgeranyl restored almost full activity. These findings suggest that all beta subunits, with the exception of beta5, interact equally well with PtdIns 3-kinase. In contrast, the composition of the gamma subunit and its prenyl group markedly affects the ability of the betagamma dimer to stimulate PtdIns 3-kinase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322106     DOI: 10.1074/jbc.M406071200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Authors:  Minghao Sun; Jonathan R Hart; Petra Hillmann; Marco Gymnopoulos; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  The inhibitory effect of Gβγ and Gβ isoform specificity on ENaC activity.

Authors:  Ling Yu; Otor Al-Khalili; Billie Jeanne Duke; James D Stockand; Douglas C Eaton; Hui-Fang Bao
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

3.  Gnb isoforms control a signaling pathway comprising Rac1, Plcβ2, and Plcβ3 leading to LFA-1 activation and neutrophil arrest in vivo.

Authors:  Helena Block; Anika Stadtmann; Daniel Riad; Jan Rossaint; Charlotte Sohlbach; Giulia Germena; Dianqing Wu; Scott I Simon; Klaus Ley; Alexander Zarbock
Journal:  Blood       Date:  2015-10-14       Impact factor: 22.113

4.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

5.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

6.  Prenylation-deficient G protein gamma subunits disrupt GPCR signaling in the zebrafish.

Authors:  Timothy Mulligan; Heiko Blaser; Erez Raz; Steven A Farber
Journal:  Cell Signal       Date:  2009-09-26       Impact factor: 4.315

7.  Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12.

Authors:  Jiean Huang; Ancy D Nalli; Sunila Mahavadi; Divya P Kumar; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-27       Impact factor: 4.052

8.  Differential inhibitor of Gbetagamma signaling to AKT and ERK derived from phosducin-like protein: effect on sphingosine 1-phosphate-induced endothelial cell migration and in vitro angiogenesis.

Authors:  María Luisa Guzmán-Hernández; Aleida Vázquez-Macías; Jorge Carretero-Ortega; Ricardo Hernández-García; Alejandro García-Regalado; Ivette Hernández-Negrete; Guadalupe Reyes-Cruz; J Silvio Gutkind; José Vázquez-Prado
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

9.  Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop.

Authors:  Marion Cornu; Jiang-Yan Yang; Evrim Jaccard; Carine Poussin; Christian Widmann; Bernard Thorens
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival.

Authors:  Victor May; Eve Lutz; Christopher MacKenzie; Kristin C Schutz; Kate Dozark; Karen M Braas
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.